Indigo Biosciences Raises $500K in Series B Financing

indigoIndigo Biosciences, a State College, PA-based provider of both products and services focused on nuclear receptors, raised $500k in Series B financing.

The round – which has an overall goal of $1.5m – was led by the Life Sciences Greenhouse of Central Pennsylvania (LSGPA) and AGSM, a private equity investment firm from Pittsburgh.

The company intends to use the funds to accelerate growth through new product development, continued development of a European strategy, and the expansion of domestic sales capabilities.

Founded in 2005 and led by Fred Marroni, CEO, Indigo provides screening services and assay kits for the pharmaceutical, biotechnology, agri-business, and nutriceutical industries, as well as government research agencies and academic researchers, based on its CryoMite™ technology, which provides long-term cryo-preservation of cells for shipping and storage.



Join the discussion